On July 13, 2023 Bio-Techne Corporation (NASDAQ: TECH) reported that management will host a conference call and webcast on Tuesday, August 8, 2023, at 8:00 a.m. CDT to review fourth quarter and fiscal 2023 financial results (Press release, Bio-Techne, JUL 13, 2023, https://investors.bio-techne.com/news/detail/375/bio-techne-to-host-conference-call-on-august-8-2023-to-announce-fourth-quarter-and-fiscal-2023-financial-results [SID1234633218]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Access to the discussion may be obtained as follows:
Time:
8:00 a.m. CDT
Date:
August 8, 2023
Dial-in:
1-877-300-8521 or 1-412-317-6026 (for international callers)
Conference ID:
10180893
Webcast:
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 10180893.
The replay will be available from 11:00 a.m. CDT on Tuesday, August 8, 2023, until 11:00 p.m. CDT on Friday, September 8, 2023.